Alembic Pharmaceuticals announces USFDA final approval for Nelarabine injection, 250 mg/50 mL (5 mg/mL) (Single-Dose Vial) Read more
Successful completion of USFDA inspection at Alembic Pharma Oral Solid Formulation Facility (F-I) at Panelav Read more
Eisai and Biogen’s Leqembi launch in China marks turning point in Alzheimer’s treatment, says GlobalData Read more
Oral JAK inhibitor LEQSELVI (deuruxolitinib) approved by US FDA for severe alopecia areata treatment Read more